
Mark A Clements MD PhD, CPI
Assistant Professor, Pediatrics, University of Missouri, Kansas City School of Medicine
Join to view full profile
2401 Gillham RdKansas City, MO 64108
Phone+1 816-234-3000
Dr. Clements is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children’s Mercy HospitalFellowship, Pediatric Endocrinology, 2006 - 2008
Children’s Mercy HospitalResidency, Pediatrics, 2003 - 2006
WashU MedicineClass of 2003
Certifications & Licensure
KS State Medical License 2006 - 2027
MO State Medical License 2006 - 2027
American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes Start of enrollment: 2016 Dec 29
- HCT Cash-Only INcentive to Promote Mealtime Insulin DOSE Engagement Start of enrollment: 2022 Feb 14
- A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes Start of enrollment: 2022 Mar 24
Publications & Presentations
PubMed
- The Development and Validation of Multivariable Electronic Health Record-Based Models to Predict Diabetic Ketoacidosis-Related Hospitalizations for Adults with Type 1 ...Jacob Kohlenberg, Meng Xu, Ryan Coopergard, Erika S Helgeson, Amy C Gross
Diabetes Technology & Therapeutics. 2026-05-01 - Supporting Parents of Young Children With Type 1 Diabetes Through Telehealth: Randomized Controlled Trial of the Reducing Emotional Distress for Childhood Hypoglycemia...Susana R Patton, Nicole Kahhan, Holly O'Donnell, David D Williams, Mark Clements
JMIR Pediatrics and Parenting. 2026-04-30 - Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.Carla J Greenbaum, S Alice Long, Stephen E Gitelman, Jason L Gaglia, Mark Daniels
Diabetes. 2026-03-01
Journal Articles
- Dyslipidemia and Statin Use in Youth and Adults Ages 10‐<40 Years in the T1D Exchange Clinic RegistryMichael R Rickels, Mark A Clements, Diabetes, Obesity and Metabolism
Authored Content
- ENDO 2021 Preview: Harnessing Data to Help with DiabetesMarch 2021
Press Mentions
Advancing Diabetes Care: Combating Burnout and Harnessing TechnologyAugust 4th, 2025- At-Home Digital Health Innovations Transforming Diabetes CareApril 4th, 2022
- AI Reveals Link Between Family History and Type 1 Diabetes RisksMarch 28th, 2022
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









